Suvretta Capital Management, LLC Kura Oncology, Inc. Transaction History
Suvretta Capital Management, LLC
- $2.91 Billion
- Q2 2025
A detailed history of Suvretta Capital Management, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 8,116,000 shares of KURA stock, worth $50.3 Million. This represents 1.61% of its overall portfolio holdings.
Number of Shares
8,116,000
Previous 7,439,259
9.1%
Holding current value
$50.3 Million
Previous $49.1 Million
4.62%
% of portfolio
1.61%
Previous 2.15%
Shares
19 transactions
Others Institutions Holding KURA
# of Institutions
189Shares Held
79.5MCall Options Held
53.6KPut Options Held
42.8K-
Bvf Inc San Francisco, CA7.75MShares$48.1 Million1.76% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$43.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.2MShares$38.4 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$33.2 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.2MShares$26 Million2.09% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $415M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...